Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
RTO heads into its October 22 earnings update with a stock that has bounced off a difficult summer, options traders distinctly unbothered by downside risk, and a borrow market that has loosened dramatically in recent weeks.
The clearest shift in the setup is in the lending market. Borrow availability has swung from tight to exceptionally loose: the ratio of shares available to lend versus shares already borrowed now stands at over 1,242%, compared to roughly 381% in early September. That reversal tracks a steady decline in short positions through the period, with overall estimated short shares roughly halving from above 2.9 million in mid-September to around 2.85 million today. Cost to borrow has remained consistently low throughout, around 0.47%, confirming there is no meaningful squeeze dynamic at play. Options positioning reinforces the picture of calm: the put/call ratio of 0.07 sits slightly below its 20-day average of 0.08, near the lower end of the past year's range. Taken together, the lending and options signals paint a positioning backdrop that is relaxed, not charged, heading into the print.
The bull and bear debate on Rentokil is unlikely to turn on near-term sentiment. It centres on a far more concrete question: whether the company's recovery trajectory following a significant restructuring of its US pest control footprint can translate into margin improvement at the pace the market needs. The analyst recommendation differential ranks in the 94th percentile of the coverage universe, meaning the Street is more positively skewed on this name than almost anyone. Yet the earnings history is a caution: the July 2026 print delivered a single-day decline of more than 20%, followed by a further loss over the subsequent week. The stock has shed nearly 5% over the past month, recovering 4.2% in the past week to trade at $21.09. PE has drifted up modestly over 30 days to around 14.5x, while the EV/EBITDA of 36x has ticked higher, suggesting the market is not yet pricing in a meaningful acceleration in underlying profitability. Bears will point to the July reaction as evidence that execution risk remains live.
Ownership offers one notable data point. BlackRock added more than 83 million shares in the most recent reported period, taking its stake to nearly 12.7% of shares outstanding, by far the largest holder. Janus Henderson and Invesco also added materially. Against that, Trian Fund Management trimmed its holding by around 23.5 million shares and GIC Private Limited has reduced its disclosed stake below the 5% disclosure threshold. The 13D/G register carries no activist with stated intent to push for change, though positions are as-last-disclosed and the picture can shift without notice.
The October 22 print will test whether the operational improvements underway in the North American pest control business are producing the kind of organic revenue and margin momentum that can rebuild credibility with investors still processing the summer's shock decline.
See the live data behind this article on ORTEX.
Open RTO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
